» Articles » PMID: 20505215

Proteins Required for Centrosome Clustering in Cancer Cells

Overview
Journal Sci Transl Med
Date 2010 May 28
PMID 20505215
Citations 102
Authors
Affiliations
Soon will be listed here.
Abstract

Current cancer chemotherapies are limited by the lack of tumor-specific targets, which would allow for selective eradication of malignant cells without affecting healthy tissues. In contrast to normal cells, most tumor cells contain multiple centrosomes, which tend to cause the formation of multipolar mitotic spindles, chromosome segregation defects, and cell death. Nevertheless, many cancer cells divide successfully because they can cluster multiple centrosomes into two spindle poles. Inhibition of this centrosomal clustering, with consequent induction of multipolar spindles and subsequent cell death, would specifically target cancer cells and overcome one limitation of current cancer treatments. We have performed a genome-wide RNA interference screen to identify proteins involved in the prevention of spindle multipolarity in human cancer cells with supernumerary centrosomes. The chromosomal passenger complex, Ndc80 microtubule-kinetochore attachment complex, sister chromatid cohesion, and microtubule formation via the augmin complex were identified as necessary for centrosomal clustering. We show that spindle tension is required to cluster multiple centrosomes into a bipolar spindle array in tumor cells with extra centrosomes. These findings may explain the specificity of drugs that interfere with spindle tension for cancer cells and provide entry points for the development of therapeutics.

Citing Articles

OTUD6B regulates KIFC1-dependent centrosome clustering and breast cancer cell survival.

Marotta V, Sabat-Pospiech D, Fielding A, Ponsford A, Thomaz A, Querques F EMBO Rep. 2025; 26(4):1003-1035.

PMID: 39789388 PMC: 11850729. DOI: 10.1038/s44319-024-00361-w.


FOXM1 Transcriptionally Co-Upregulates Centrosome Amplification and Clustering Genes and Is a Biomarker for Poor Prognosis in Androgen Receptor-Low Triple-Negative Breast Cancer.

Rida P, Baker S, Saidykhan A, Bown I, Jinna N Cancers (Basel). 2024; 16(18).

PMID: 39335162 PMC: 11429756. DOI: 10.3390/cancers16183191.


Kinesins regulate the heterogeneity in centrosome clustering after whole-genome duplication.

Lau T, Ma H, Poon R Life Sci Alliance. 2024; 7(10).

PMID: 39074902 PMC: 11287020. DOI: 10.26508/lsa.202402670.


Cell cycle-dependent centrosome clustering precedes proplatelet formation.

Becker I, Wilkie A, Nikols E, Carminita E, Roweth H, Tilburg J Sci Adv. 2024; 10(25):eadl6153.

PMID: 38896608 PMC: 11186502. DOI: 10.1126/sciadv.adl6153.


Nek2A prevents centrosome clustering and induces cell death in cancer cells via KIF2C interaction.

Kalkan B, Ozcan S, Cicek E, Gonen M, Acilan C Cell Death Dis. 2024; 15(3):222.

PMID: 38493150 PMC: 10944510. DOI: 10.1038/s41419-024-06601-0.